Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€14.19
26.05.24
-
26.05.25
19.87%
08.06.24

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.17
26.05.24
-
26.05.25
5.40%
08.06.24

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€14.19
25.05.24
€28.00
25.05.25
19.87%
08.06.24

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€14.19
25.05.24
€142.00
25.05.25
19.87%
08.06.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€4.66
24.05.24
-
24.05.25
-11.16%
25.05.24

buy
Capricor Therapeutics Inc

Start price
Target price
Perf. (%)
€4.33
19.05.24
€10.00
-
20.05.24

MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.82
19.05.24
€2.00
-
20.05.24

Insmed Inc.

Start price
Target price
Perf. (%)
€22.80
17.05.24
€18.00
28.02.26
-10.53%
26.05.24

Could be very worthwhile Investment >20% year
Savara Inc.

Start price
Target price
Perf. (%)
€4.34
15.05.24
-
15.05.25
-14.75%
25.05.24

buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.14
15.05.24
-
15.05.25
-16.67%
24.05.24

Risky Investment
Novavax Inc.

Start price
Target price
Perf. (%)
€12.05
15.05.24
€2.00
15.05.25
17.78%
26.05.24

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€12.15
13.05.24
-
13.05.25
16.83%
25.05.24

Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Novavax Inc.

Start price
Target price
Perf. (%)
€11.90
13.05.24
-
13.05.25
19.28%
25.05.24

Insmed Inc.

Start price
Target price
Perf. (%)
€23.60
13.05.24
€15.00
13.05.25
0.00%
14.05.24

Could be very worthwhile Investment >20% year
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.82
13.05.24
€20.00
16.03.25
-
13.05.24

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.15
12.05.24
-
12.05.25
-21.69%
24.05.24

Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€1.83
11.05.24
€1.00
11.05.25
-3.66%
19.05.24

Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.12
11.05.24
€1.00
11.05.25
-8.33%
19.05.24

MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.14
11.05.24
€1.02
11.05.25
30.98%
19.05.24

buy
Biolife Solutions Inc

Start price
Target price
Perf. (%)
€18.50
11.05.24
€32.00
11.05.25
8.11%
19.05.24

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€8.70
11.05.24
€82.00
11.05.25
39.26%
19.05.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Novavax Inc.

Start price
Target price
Perf. (%)
€9.37
10.05.24
-
10.05.25
-7.12%
12.05.24

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.37
10.05.24
-
10.05.25
-27.99%
12.05.24

Risky Investment
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€5.17
10.05.24
-
10.05.25
-19.69%
14.05.24

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.96
10.05.24
-
10.05.25
4.80%
11.05.24

Could be worthwhile Investment >10% per year